Skip to main content

and
  1. Article

    Open Access

    Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

    Subclonal evolution during primary breast cancer treatment is largely unexplored. We aimed to assess the dynamic changes in subclonal composition of treatment-naïve breast cancers during neoadjuvant chemotherapy.

    Andreas Venizelos, Christina Engebrethsen, Wei Deng, Jürgen Geisler in Genome Medicine (2022)